arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

SELLAS Life Sciences Group, Inc.

SLS Health Care Biotechnology: Pharmaceutical Preparations
$12.15
▲ +0.6% Today
as of Jul 22, 16:54 ET
Last 30 days +54.28% Jun 12 → Jul 22
$6.90 $9.19 $11.49 $13.79 $16.08 Jun 12 Jun 22 Jun 29 Jul 08 Jul 15 Jul 22
Open
$8.85
High
$9.03
Low
$8.12
Volume
$7M
Avg Vol
$6M
Mkt Cap
$2.3B
P/E (TTM)
Beta
52w High
$9.51
52w Low
$1.39
Div Yield
Shares Out
$181M

Recent Press Releases & News last 60 days · 25 items

▸ Show all 25 press releases & news Free account →

Overview

52-week range
$1.39
$9.51
100% of range
Avg surprise (last 0)
Avg reaction (last 2)
-4.5%
0% positive
Latest IV / EM
227%
EM ±13.4% · $12 · Jul 24

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.33$-0.26$-0.19$-0.12$-0.05 Actual $-0.31Actual $-0.33Actual $-0.21Actual $-0.13Actual $-0.10Actual $-0.07Actual $-0.07Actual $-0.06Actual $-0.05 JunSepMarJunSepMar/2025Jun/2025SepMar/2026
Revenue vs Net Income Revenue Net income
$-8M$-8M$-7M$-7M$-6M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 12, 2026Mar/2026 $-0.05 +28.6% -0.6% earnings
Tue Sep 30, 2025Sep 2025 $-0.06 financials
Tue Aug 12, 2025Jun/2025 $-0.07 earnings
Tue May 13, 2025Mar/2025 $-0.07 -8.4% earnings
Mon Sep 30, 2024Sep 2024 $-0.10 financials
Sun Jun 30, 2024Jun 2024 $-0.13 financials
Sun Mar 31, 2024Mar 2024 $-0.21 financials
Sat Sep 30, 2023Sep 2023 $-0.33 financials
Fri Jun 30, 2023Jun 2023 $-0.31 financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Tue Aug 11, 2026Jun/2026OTHER -$0.07

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-9M$-7M$-7M$-6M$-7M$-8M
Net income$-8M$-7M$-7M$-6M$-7M$-7M
EPS (diluted)$-0.05$-0.06$-0.07$-0.07$-0.10$-0.13

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$107M$72M$44M$25M$28M$14M$21M$9M
Inventory
Total current assets$111M$75M$49M$29M$32M$16M$24M$12M
Total assets$114M$78M$52M$32M$35M$19M$27M$15M
Long-term debt
Total liabilities$7M$7M$6M$6M$7M$10M$11M$12M
Total equity$107M$71M$46M$26M$28M$9M$16M$3M

Implied volatility — last 90 days

115%169%222%276%330% Jun 08 — IV 142% · EM ±11.8%Jun 09 — IV 134% · EM ±9.7%Jun 10 — IV 169% · EM ±10.0%Jun 11 — IV 283% · EM ±11.8%Jun 15 — IV 143% · EM ±10.3%Jun 16 — IV 121% · EM ±7.1%Jun 17 — IV 147% · EM ±6.1%Jun 19 — IV 320% · EM ±35.4%Jun 22 — IV 123% · EM ±10.3%Jun 23 — IV 155% · EM ±11.2%Jun 24 — IV 116% · EM ±6.8%Jun 25 — IV 186% · EM ±7.8%Jun 29 — IV 221% · EM ±52.2%Jun 30 — IV 231% · EM ±53.7%Jul 01 — IV 199% · EM ±8.3%Jul 03 — IV 216% · EM ±23.9%Jul 06 — IV 214% · EM ±17.9%Jul 07 — IV 208% · EM ±15.0%Jul 08 — IV 180% · EM ±10.7%Jul 09 — IV 224% · EM ±9.4%Jul 13 — IV 192% · EM ±16.1%Jul 14 — IV 204% · EM ±14.8%Jul 15 — IV 156% · EM ±9.2%Jul 16 — IV 330% · EM ±13.8%Jul 20 — IV 218% · EM ±18.2%Jul 21 — IV 205% · EM ±14.8%Jul 22 — IV 227% · EM ±13.4%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.